An adverse drug reaction reporting system as an integral part of a drug-usage evaluation program.
The Adverse Drug Reaction program at CSMC identifies patients whose charts have been encoded with an ICD-9 code of E930 through E949, inclusively. Incidences per drug or drug category have permitted the Department of Pharmacy, acting through the Pharmacy and Therapeutics Committee, to review patient charts, identify trends and risk factors, and subsequently develop usage criteria for DUE studies. It is hoped that these activities will result in an improvement in usage of these drugs and a reduction in adverse drug reactions to them.
Cedars-Sinai Medical Center, Los Angeles, CA.
E
E
Saltiel
R
R
Shane
D004077:Digoxin / Q000009:adverse effects; D004363:Drug Utilization; D064420:Drug-Related Side Effects and Adverse Reactions; D005069:Evaluation Studies as Topic; D006746:Hospital Bed Capacity, 500 and over; D006801:Humans; D015141:Los Angeles; D010606:Pharmacy and Therapeutics Committee / Q000458:organization & administration*; D011358:Product Surveillance, Postmarketing